SOLIRIS
SOLIRIS (eculizumab) is a monoclonal antibody that binds to proteins in the blood that can destroy red blood cells. Specifically, it is a complement inhibitor antibody used to treat myasthenia gravis and certain hemolytic (blood-related) syndromes.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
What it treats
Myasthenia Gravis (in patients who are
acetyl-choline receptor antibody positive),
Paroxysmal Nocturnal Hemoglobinuria (PNH),
Atypical Hemolytic Uremic Syndrome (aHUS)
Prescribed by
Neurologists
How it’s administered
Intravenous (IV) infusion
Frequency
Every other week
Length of treatment
About 45 minutes